Insider · CIK 0001308105

SKIBSTED RUSSELL

Reports to the SEC for 9 companies · VERO BEACH, FL

sec.gov

Transactions

Companies

Filings

CIK

0001308105

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-26	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+11.9K sh	—	—	17,323
2026-06-30	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+3,277 sh	$1.93	+$6,324.61	16,689
2026-06-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,654 sh	$2.22	+$5,891.88	13,412
2026-05-29	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,292 sh	$2.57	+$5,890.44	10,758
2026-05-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,984 sh	$2.97	+$5,892.48	8,466
2026-04-30	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,190 sh	$2.69	+$5,891.1	6,498
2026-04-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+1,984 sh	$2.97	+$5,892.48	4,308
2026-03-31	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,324 sh	$2.54	+$5,891.34	2,324
2025-10-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+108K sh	—	—	108,000
2025-10-01	PCSAProcessa Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Chief Financial Officer	AAward	+324K sh	—	—	324,000
2025-07-24	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+1.78M sh	—	—	1,803,044
2024-07-16	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+28K sh	—	—	28,000
2023-11-21	ALIMERA SCIENCES INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+50K sh	—	—	50,000
2023-03-26	ALIMERA SCIENCES INCA Award	Chief Financial Officer & SVP	AAward	+58K sh	—	—	75,500
2023-01-09	ALIMERA SCIENCES INCA Award	Chief Financial Officer & SVP	AAward	+17.5K sh	—	—	17,500
2023-01-09	ALIMERA SCIENCES INCEmployee Stock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+52.5K sh	—	—	52,500
2022-09-09	RMTIROCKWELL MEDICAL, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+80K sh	—	—	80,000
2020-09-15	RMTIROCKWELL MEDICAL, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+600K sh	—	—	600,000
2020-09-15	RMTIROCKWELL MEDICAL, INC. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+150K sh	—	—	150,000
2018-12-18	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+22.5K sh	—	—	31,859
2018-12-18	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−7,781 sh	$1.03	−$8,014.43	24,078
2018-12-18	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−22.5K sh	—	—	11,250
2018-10-04	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+11.3K sh	—	—	13,250
2018-10-04	LCTXLineage Cell Therapeutics, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,891 sh	$2.22	−$8,638.02	9,359
2018-10-04	LCTXLineage Cell Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−11.3K sh	—	—	33,750
2018-03-15	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2017-08-23	LCTXLineage Cell Therapeutics, Inc.P Purchase	Chief Financial Officer	PPurchase	+2,000 sh	$2.64	+$5,284.8	2,000
2017-06-06	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Chief Financial Officer	AAward	+250K sh	—	—	250,000
2016-09-08	LCTXLineage Cell Therapeutics, Inc. · Option to Purchase Common SharesA Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2013-03-08	AEOLUS PHARMACEUTICALS, INC.Non-qualified Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000
2012-05-23	AEOLUS PHARMACEUTICALS, INC.P Purchase	Chief Financial Officer	PPurchase	+7,027 sh	$0.24	+$1,678.048	17,027
2011-05-18	AEOLUS PHARMACEUTICALS, INC.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$0.41	+$2,050	5,000
2011-05-18	AEOLUS PHARMACEUTICALS, INC.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$0.42	+$2,100	10,000
2011-05-18	AEOLUS PHARMACEUTICALS, INC.P Purchase	Chief Financial Officer	PPurchase	+10K sh	$0.43	+$4,300	10,000
2005-07-25	Talon Therapeutics, Inc.Employee Stock Option (Pursuant to Rule 16b-3; right to buy)A Award	Chief Financial Officer	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Jul 284
SKIBSTED RUSSELL0000897069-26-001558
SEC(opens sec.gov)
Jul 14
SKIBSTED RUSSELL0000897069-26-001478
SEC(opens sec.gov)
Jun 164
SKIBSTED RUSSELL0000897069-26-001412
SEC(opens sec.gov)
Jun 14
SKIBSTED RUSSELL0000897069-26-001293
SEC(opens sec.gov)
May 194
SKIBSTED RUSSELL0000897069-26-001171
SEC(opens sec.gov)
May 14
SKIBSTED RUSSELL0000897069-26-001008
SEC(opens sec.gov)
Apr 174
SKIBSTED RUSSELL0000897069-26-000902
SEC(opens sec.gov)
Apr 14
SKIBSTED RUSSELL0000897069-26-000754
SEC(opens sec.gov)
Oct 34
SKIBSTED RUSSELL0000897069-25-001547
SEC(opens sec.gov)
Jul 284
SKIBSTED RUSSELL0000897069-25-001217
SEC(opens sec.gov)
Jul 184
SKIBSTED RUSSELL0000897069-24-001518
SEC(opens sec.gov)
Nov 284
SKIBSTED RUSSELL0001104659-23-121644
SEC(opens sec.gov)
Mar 284
SKIBSTED RUSSELL0000899243-23-009832
SEC(opens sec.gov)
Jan 104
SKIBSTED RUSSELL0001474506-23-000019
SEC(opens sec.gov)
Sep 134
SKIBSTED RUSSELL0001104659-22-099655
SEC(opens sec.gov)
Sep 164
SKIBSTED RUSSELL0001628280-20-013684
SEC(opens sec.gov)
Dec 204
SKIBSTED RUSSELL0001209191-18-063604
SEC(opens sec.gov)

Companies

Address

C/O PROCESSA PHARMACEUTICALS, INC. 601 21ST STREET SUITE 300

VERO BEACH, FL, 32960